APA (7th ed.) Citation

S, E., AP, P., CA, M., PB, R., BG, P., DP, D., . . . CG, L. (2019). Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimer's & dementia : the journal of the Alzheimer's Association, 15(11), 1427. https://doi.org/10.1016/j.jalz.2019.06.4946

Chicago Style (17th ed.) Citation

S, Ehrhardt, et al. "Escitalopram for Agitation in Alzheimer's Disease (S-CitAD): Methods and Design of an Investigator-initiated, Randomized, Controlled, Multicenter Clinical Trial." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 15, no. 11 (2019): 1427. https://doi.org/10.1016/j.jalz.2019.06.4946.

MLA (9th ed.) Citation

S, Ehrhardt, et al. "Escitalopram for Agitation in Alzheimer's Disease (S-CitAD): Methods and Design of an Investigator-initiated, Randomized, Controlled, Multicenter Clinical Trial." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 15, no. 11, 2019, p. 1427, https://doi.org/10.1016/j.jalz.2019.06.4946.